Quote:

---

Which is why after the protocol change for CD-12 in May allowing other treatments in, JL's argument he presented on the call for enrollment problems is somewhat moot.

---

It's totally moot and I almost posted something about that too. Perhaps JL wasn't completely aware of May's exclusion criteria update but it hardly matters at this point. If you like your Plasma and Remdesivir you can keep your Plasma and Remdesivir.

Quote:

---

The compelling offer CYDY can and has to make to the sites is this: if you have severe or critical patients that worsen on your SOC treatments, you can ALWAYS enroll them into the trial to give them another chance, without harming them since it is perfectly safe and we take them all...

---

Agreed! The poor folks not doing well with SOC are exactly the ones we want for the trial. Let's see how CYDY mgmt backs up their assurances on increasing enrollment. I want to see a significant uptick by early November.